NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/31/2023
Back to search
Official data from USPTO
OSNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OSNA
ST13
US500000087927734Class
5, 9, 10, 42, 44
Filing
87927734
Registration
7204197
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
10/31/2023
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
05/18/2018
Registration date
10/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
10/31/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
Kobe, Hyogo, JP
Examiner
RADEMACHER, APRIL
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. C. (pessoa física)
Representatives
Virginia Wolk Marino CROWELL & MORING
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or pharmaceutical purposesreagents for detecting metastasis of cancer; testing reagents and preparations for medical or veterinary purposes; pharmaceutical preparations for in vitro diagnosis; reagents for medical usereagents for genetic test; reagents for medical usereagents for amplification and detection of genes; reagents for medical uselymph node solubilizing reagents; reagents for medical usereagents for protein test; reagents for medical usereagents for cancer recurrence prediction test; reagents for medical usereagents for anticancer drug sensitivity prediction test; diluents for medical or veterinary purposes; diluents for medical or clinical diagnostic use; diluents for genetic test for medical or clinical diagnostic use; reference control materials for medical use; quality control standard solutions and quality control reagents for testing and calibrating medical apparatus and reagents
Class 9
Gene amplification or detection device for scientific or research usefor detecting metastasis of cancer; laboratory apparatus and instrumentsfor genetic testing for scientific and research purposes; measuring or testing machines and instruments for analyzing bloodbody fluidtissue or other biological samples not for medical purposes
Class 10
Diagnostic apparatus and instruments for medical purposesfor testing DNA or RNA; diagnostic or measuring apparatus and instruments for medical purposes in the nature of genetic testing apparatus and instrumentsgene amplification detectorcancer metastasis analyzercell cycle analyzercancer recurrence prediction testing apparatus and instrumentsanticancer drug sensitivity prediction testing apparatus and instrumentssample transfer apparatussample container transfer apparatussample rack transfer apparatus; measuring apparatus and instruments for medical purposes for analyzing genes; pipettes for medical purposes; containers for samples for in vitro diagnosis; sampling bottles for medical purposes
Class 42
Medical or scientific research on cancer diagnosis; medical research; providing information relating to medical research; testingexamination or research of reagents and other medicines; testingexamination or research of medical apparatus and instruments and other machines; technological advice relating to medical apparatus and instrumentslaboratory apparatus and instrumentsmeasuring or testing machines and instrumentstesting apparatus and instrumentscomputers and other machines; rental of gene amplification or detection device for scientific or research use; rental of laboratory apparatus and instruments; rental of measuring or testing machines and instruments for medical or scientific research; all of the foregoing for use with medical and scientific research in the field of cancer diagnosis
Class 44
Clinical genetic testing for detecting metastasis of cancer for diagnostic or treatment purposes; clinical testing of genes in lymph node for medical purposes; providing information relating clinical testinggenetic testing; medical analysis and evaluation of clinical laboratory tests results for diagnosis of cancer metastasis or other diseases; providing medical information in the field of genetic testing; rental of medical apparatus and instruments
Publications
History of USPTO decisions and trademark events.
48 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/03/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/03/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/03/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
06/01/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/20/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
05/20/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/16/2021
EX5G
SOU EXTENSION 5 GRANTED
11/15/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/15/2021
EXT5
SOU EXTENSION 5 FILED
11/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/08/2021
EX4G
SOU EXTENSION 4 GRANTED
05/06/2021
EXT4
SOU EXTENSION 4 FILED
05/06/2021
EEXT
SOU TEAS EXTENSION RECEIVED
05/06/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/06/2020
EX3G
SOU EXTENSION 3 GRANTED
11/04/2020
EXT3
SOU EXTENSION 3 FILED
11/04/2020
EEXT
SOU TEAS EXTENSION RECEIVED
11/04/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/11/2020
EX2G
SOU EXTENSION 2 GRANTED
02/07/2020
EXT2
SOU EXTENSION 2 FILED
02/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
02/07/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
10/08/2019
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/25/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/14/2019
EX1G
SOU EXTENSION 1 GRANTED
06/12/2019
EXT1
SOU EXTENSION 1 FILED
06/12/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/12/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/28/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2019
PUBO
PUBLISHED FOR OPPOSITION
04/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2019
ALIE
ASSIGNED TO LIE
02/22/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/28/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/27/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/27/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/23/2018
GNRT
NON-FINAL ACTION E-MAILED
06/23/2018
CNRT
NON-FINAL ACTION WRITTEN
06/23/2018
DOCK
ASSIGNED TO EXAMINER
06/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/26/2018
NWAP
NEW APPLICATION ENTERED
05/22/2018
Continuous trademark protection
Get notified about every new filing that threatens OSNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.